Cardiac Screening of Middle Aged and Older Women and Men (Master Athletes)

NCT02923518 | Completed

• 1 other identifier: 2016/21007
• Study Type: observational
• Target: 86
• Locations: 1 country
• Sites: 1

Brief Summary

In 2010 there was published new European recommendations for assessment of adult and elderly men and women, who want to start with physical activity and/or participate in endurance contests. In this study we want to test if a group of people with positive score on a self-reported questionnaire and/or high-risk score in a risk scoring system (NORRISK) have more undetected heart diseases than a control group with no reported or detected risk factors.

Conditions

Heart Disease

Keywords

Heart Screening; Master Athletes; Cardiovascular Disease

Outcome Measures

Primary Outcomes (1)

• Differences among two groups of senior athletes in detecting heart diseases by a screening program

  Examine if a simple screening program is efficient in detecting heart diseases

  One year

Study Arms (2)

Inclusion group

Inclusion group: Those with a positive score in a questionnaire including symptoms and family history and/or high risk-score in the NORRISK-score system.

Other: Questionnaire

Control group

Those without a positive score on the two scores listed above.

Other: Questionnaire

Interventions

Questionnaire OTHER

Observational study without any intervention described under intervention type

Control group; Inclusion group

Eligibility Criteria

• Age: 35 Years - 85 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Senior men and women \< 35 yrs participating in long-enurance competitions. 40 persons in a group with positive score and one group without.

You may qualify if:

• \> 35 yrs old Master athletes Positive score on symptom based questionnaire or high risk score No known heart disease Participated in long-term endurance competitions

You may not qualify if:

• \< 35 yrs old Known heart disease

Sponsors & Collaborators

• LHL Helse: lead

Study Sites (1)

LHL-clinics Feiring

Feiring, 2093, Norway

Location

MeSH Terms

Conditions

Heart Diseases; Cardiovascular Diseases

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Hege Lundring, M.D.

  General manager the LHL-clinics

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 1, 2016
• First Posted: October 4, 2016
• Study Start: October 1, 2016
• Primary Completion: November 1, 2017
• Study Completion: November 1, 2017
• Last Updated: August 31, 2018

Record last verified: 2018-08

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)